Officially designated as a member of the Marathon of Hope Cancer Centres Network (MOHCCN) in December 2022, the Atlantic Cancer Consortium (ACC) shares the MOHCCN vision to unite Canada to cure cancer. We are aligned with the MOHCCN mission to create a national network that applies world-leading science to cancer care, with a focus on precision medicine. We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration, to increase cancer research capacity and productivity and to train the next generation of ACC cancer researchers in precision medicine.
As the smallest region joining the MOHCCN, Atlantic Canada has always taken a regionally collaborative approach to cancer research. Assembling our collective critical mass has been essential to creating a thriving cancer research environment. With the
MOHCCN, the ACC is excited to contribute to the advancement of cancer research nationally through the engagement with rural and underserved communities to deliver precision oncology opportunities, engagement with Indigenous communities to develop
a framework for collaboration, and the implementation of precision medicine in the clinical setting, immunology, metabolism, and biomarkers.